Quick Answer: What Tests Are Used for an Enlarged Prostate?
There is no single test that diagnoses every prostate problem. If you have urinary symptoms that may be caused by benign prostatic hyperplasia (BPH), your healthcare professional usually evaluates the whole clinical picture.
- Medical history and symptom assessment help determine what symptoms you have and how much they affect daily life.
- Physical examination may include a digital rectal examination (DRE) to estimate prostate size and assess for abnormalities.
- Urinalysis helps look for infection, blood, glucose and other possible causes of urinary symptoms.
- PSA testing may be considered when appropriate, but PSA alone cannot diagnose either BPH or prostate cancer.
- Post-void residual urine, uroflowmetry, ultrasound, cystoscopy or urodynamic testing may be used when additional information is needed.
Men often refer to a “prostate test,” but doctors actually use different tests for different questions.
For example, your doctor may need to determine:
- whether your prostate appears enlarged;
- whether your urinary symptoms are likely related to BPH;
- whether your bladder is emptying properly;
- whether infection or another urinary condition is present;
- or whether further evaluation for prostate cancer is appropriate.
Therefore, the appropriate testing depends on why you are being evaluated.
Why Are Prostate Tests Performed?
Prostate and urinary tests may be used for several different purposes.
-
To investigate urinary symptoms
Weak stream, difficulty starting urination, urgency, frequency, nocturia and incomplete emptying may occur with BPH but can also have other causes. -
To assess prostate enlargement
Examination, PSA and imaging may provide information about prostate size when clinically useful. -
To evaluate bladder emptying
Post-void residual measurement and uroflowmetry can provide additional information about urinary function. -
To look for other conditions
Urine testing and selected additional investigations can identify infection, blood in the urine, bladder problems or other abnormalities. -
To assess prostate-cancer risk when appropriate
PSA testing may be part of prostate-cancer screening or further evaluation, but an abnormal PSA does not automatically mean cancer.
What Is Usually Done First for Possible BPH?
Current BPH evaluation does not automatically begin with ultrasound.
For men presenting with bothersome lower urinary tract symptoms that may be related to BPH, the initial evaluation generally includes:
- A detailed medical history
- A physical examination
- A standardized urinary symptom questionnaire, such as the International Prostate Symptom Score (IPSS)
- Urinalysis
Other tests are then selected according to what additional information the doctor needs.
1. Medical History and Symptom Score
Before ordering more specialized tests, your healthcare professional will usually ask about:
- difficulty starting urination;
- weak or interrupted urine flow;
- urinary urgency;
- frequent urination;
- waking at night to urinate;
- a feeling of incomplete bladder emptying;
- urinary leakage;
- pain or burning;
- blood in the urine;
- previous urinary or prostate procedures;
- medicines you take;
- diabetes and other medical conditions;
- fluid, caffeine and alcohol intake;
- and how much the symptoms bother you.
International Prostate Symptom Score (IPSS)
The IPSS is a validated questionnaire that asks about seven common urinary symptoms and includes a separate quality-of-life question.
It can help measure symptom severity and track whether symptoms improve or worsen over time.
A Symptom Score Does Not Diagnose BPH by Itself
The IPSS measures symptoms. It does not prove that the prostate is the cause. Your doctor interprets the score together with your history, examination and other findings.
2. Digital Rectal Examination (DRE)
During a digital rectal examination, a healthcare professional gently inserts a lubricated, gloved finger into the rectum to feel the back surface of the prostate.
A DRE may provide information about:
- an approximate prostate size;
- prostate consistency;
- tenderness;
- asymmetry;
- or an abnormal area that may require further evaluation.
3. PSA Blood Test
PSA stands for prostate-specific antigen. It is a protein produced by prostate tissue that can be measured in a blood sample.
A PSA level can be influenced by several factors, including:
- benign prostate enlargement;
- prostatitis or inflammation;
- prostate cancer;
- urinary retention;
- recent prostate or urinary procedures;
- and some medications.
Therefore:
- A high PSA does not automatically mean prostate cancer.
- A low PSA cannot guarantee that prostate cancer is absent.
- A newly elevated result may sometimes be repeated before moving to more invasive testing, depending on the clinical circumstances.
For men being evaluated for BPH, PSA may also provide information that helps estimate prostate volume and future BPH progression risk in selected clinical situations.
Read our dedicated PSA and Prostate guide .
4. Urinalysis
A urine test is an important part of the initial assessment of men with urinary symptoms.
Urinalysis may identify:
- blood in the urine;
- signs of urinary infection;
- glucose in the urine;
- protein;
- or other findings requiring further investigation.
This matters because urinary symptoms should not automatically be attributed to an enlarged prostate.
If symptoms suggest a urinary tract infection, a urine culture may also be appropriate.
5. Post-Void Residual Urine Test
A post-void residual (PVR) test measures how much urine remains in your bladder after you have tried to empty it.
It may be measured using:
- a bladder ultrasound device; or
- in selected situations, a catheter.
A higher residual volume may suggest that the bladder is not emptying efficiently, although the result must be interpreted together with other clinical findings.
6. Uroflowmetry: The Urine Flow Test
Uroflowmetry measures how quickly and how much urine comes out while you urinate.
The test may provide information about:
- maximum urine-flow rate;
- the pattern of the urine stream;
- the amount of urine passed;
- and possible bladder-outlet obstruction.
A Slow Flow Does Not Automatically Prove BPH
Slow urine flow may result from prostate obstruction, but it can also occur if the bladder muscle is weak or from other urinary tract conditions. The result must be interpreted in context.
7. Ultrasound for an Enlarged Prostate
Ultrasound can be useful, but it is not automatically required as the first test for every man with urinary symptoms.
Depending on the clinical situation, ultrasound may help assess:
- prostate size;
- bladder volume;
- post-void residual urine;
- kidneys and upper urinary tract;
- or anatomy before certain BPH procedures.
Prostate size can be assessed with different imaging approaches when the information would influence treatment selection.
8. Cystoscopy
A cystoscopy uses a thin instrument with a camera to examine the inside of the urethra and bladder.
It is generally used selectively rather than routinely for every man with BPH.
A urologist may consider it when there is a need to investigate:
- blood in the urine;
- possible urethral narrowing;
- bladder stones;
- bladder abnormalities;
- unexplained urinary symptoms;
- or anatomy before some procedures.
9. Urodynamic Testing
Urodynamic tests examine how the bladder, urethra and urinary sphincters store and release urine.
They can include:
- pressure-flow studies;
- cystometry;
- uroflowmetry;
- and other measurements of bladder function.
In uncomplicated BPH, invasive urodynamic testing is not routinely necessary during the initial evaluation.
It may become useful when the diagnosis is uncertain or when doctors need to distinguish obstruction from poor bladder-muscle function or another urinary problem.
10. Is a Prostate Biopsy a Routine BPH Test?
No. A prostate biopsy is not routinely performed simply because a man has an enlarged prostate or urinary symptoms.
Biopsy may be considered when the clinical evaluation raises sufficient concern for prostate cancer.
Modern prostate-cancer assessment may also use:
- repeat PSA testing;
- risk calculators;
- additional blood or urine biomarkers in selected patients;
- multiparametric MRI;
- and prostate biopsy when indicated.
Who Should Have Prostate Testing?
This question has two different answers depending on whether we are discussing urinary symptoms/BPH or prostate-cancer screening.
1. Testing for Urinary Symptoms or Possible BPH
You should discuss medical evaluation if you develop persistent or bothersome symptoms such as:
- weak urine flow;
- difficulty starting urination;
- frequent urination;
- repeated nighttime urination;
- urgency;
- incomplete bladder emptying;
- or urinary retention.
Evaluation is based on your symptoms and health situation rather than waiting until a particular birthday.
2. PSA Screening for Prostate Cancer
PSA screening is different from evaluating BPH symptoms.
Current professional recommendations emphasize shared decision-making rather than telling every man to have an annual PSA test after age 50.
The appropriate starting age and screening interval depend on factors including:
- age;
- family history of prostate cancer;
- Black ancestry;
- known inherited genetic risk;
- previous PSA values;
- overall health and life expectancy;
- and the patient’s preferences after discussing benefits and harms.
There Is No Universal “PSA Every Year After 50” Rule
Screening recommendations differ somewhat among professional organizations. Current guidance generally favors an individualized, risk-based discussion rather than automatic annual testing for every man.
Men with increased prostate-cancer risk may be advised to begin that discussion earlier than men at average risk.
Why Isn’t PSA Screening Automatic for Everyone?
PSA testing can help identify men who may have clinically significant prostate cancer, but screening also has potential disadvantages.
Possible benefits include:
- detecting some important cancers before symptoms develop;
- identifying men who need additional evaluation;
- and reducing metastatic disease or prostate-cancer mortality in some screened populations.
Possible harms include:
- false-positive PSA results;
- anxiety and repeated testing;
- unnecessary biopsy;
- overdiagnosis of cancers that might never have caused harm;
- and overtreatment with potential urinary and sexual side effects.
That balance is why screening decisions should be individualized.
What Happens If a Prostate Test Is Abnormal?
An abnormal result usually leads to interpretation and further evaluation—not an immediate diagnosis.
For example:
-
Raised PSA
Your doctor may consider repeating the PSA and reviewing other factors before recommending further investigation. -
High post-void residual
Further assessment may determine whether prostate obstruction, bladder dysfunction or another problem is contributing. -
Slow uroflowmetry
The result may need to be interpreted with bladder volume, PVR and other findings. -
Blood in the urine
This may require a separate hematuria evaluation rather than assuming BPH is responsible. -
Abnormal DRE
Further prostate-cancer evaluation may be considered depending on the overall clinical picture.
Seek Prompt Medical Attention If You:
- cannot urinate at all;
- develop painful or frequent urination together with fever or chills;
- notice significant blood in your urine;
- develop severe lower abdominal pain with inability to empty your bladder;
- or become significantly unwell after an invasive prostate or urinary procedure.
Complete inability to urinate may represent acute urinary retention and requires prompt medical assessment.
Dr. Albana’s Note
When patients ask me which “prostate test” they need, I first ask what problem we are trying to investigate.
A man with a weak urine stream may need a different evaluation from a man with an elevated PSA but no urinary symptoms. A man with burning urination and fever may need an infection assessment rather than simply an ultrasound of his prostate.
The most useful test is therefore not necessarily the most sophisticated one. It is the test that answers the clinical question we actually need to answer.
For suspected BPH, history, symptoms, examination and urine testing often provide the starting point. Additional tests can then be selected when they will change diagnosis, counseling or treatment.
— Dr. Albana Greca, MD, MMedSc, Family Physician / General Practitioner
Most Asked Questions About Prostate Tests
What is the best test for an enlarged prostate?
There is no single best test. Evaluation usually starts with medical history, physical examination, symptom assessment and urinalysis. PSA, post-void residual measurement, uroflowmetry or imaging may be added when clinically useful.
Can a PSA test diagnose BPH?
No. PSA may be higher in men with larger prostates, but it cannot diagnose BPH by itself. PSA can also be affected by inflammation, urinary retention, prostate cancer and other factors.
Can PSA tell whether an enlarged prostate is cancer?
No. PSA helps estimate prostate-cancer risk but does not by itself distinguish BPH from cancer. An abnormal result must be interpreted with other clinical information.
Is ultrasound the first test for BPH?
Not necessarily. Current BPH evaluation generally starts with history, physical examination, standardized symptom assessment and urinalysis. Ultrasound is used when information about prostate size, bladder emptying or the urinary tract would be useful.
Does every man need a PSA test every year after age 50?
No. Modern prostate-cancer screening recommendations emphasize individualized decision-making based on age, prostate-cancer risk, previous PSA results, general health and patient preferences rather than automatic annual screening for every man.
Does a DRE diagnose prostate cancer?
No. A DRE can identify prostate findings that may require further investigation, but it cannot confirm or exclude prostate cancer by itself.
Do I need a biopsy if my prostate is enlarged?
Not automatically. BPH itself does not require a prostate biopsy. Biopsy is considered when there is sufficient concern for prostate cancer after appropriate evaluation.
Related BPH Guides
Medical References
-
Goueli R, et al.
Management of Lower Urinary Tract Symptoms Attributed to Benign
Prostatic Hyperplasia: AUA Guideline (2026) Part I:
Presentation and Evaluation.
Journal of Urology. 2026.
AUA BPH Guideline -
American Urological Association / Society of Urologic Oncology.
Early Detection of Prostate Cancer Guideline.
2023; amended 2026.
AUA/SUO Early Detection Guideline -
National Institute of Diabetes and Digestive and Kidney Diseases.
Prostate Tests.
NIDDK Prostate Tests -
National Institute of Diabetes and Digestive and Kidney Diseases.
Enlarged Prostate (Benign Prostatic Hyperplasia).
NIDDK BPH -
U.S. Preventive Services Task Force.
Prostate Cancer: Screening.
Current recommendation under update as of 2026.
USPSTF
Medical information notice: This article provides general educational information and does not replace individualized medical evaluation. Which tests are appropriate depends on your symptoms, age, risk factors, examination findings, previous results and overall health.
Written & medically reviewed by Dr. Albana Greca, MD, MMedSc • Family Physician / General Practitioner • Last medically reviewed: August 2026